Evidence map›Paper›PMID 32399636›Full record

ArticleEJNMMI physics2020

Inter-observer variability of

Nicolas Meyers, Alexandre Jadoul, Claire Bernard, Jean Delwaide, Anne Lamproye, Olivier Detry, Pierre Honoré, Laurent Gerard, Roland Hustinx

Open access · goldAbstract read
In one paragraph

Article in EJNMMI physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Utility of pre-procedural [European journal of nuclear medicine and molecular imaging · 2025
    Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Nicolas MeyersDivision of Nuclear Medicine and Oncological Imaging, CHU de Liege, University Hospital of Liege, B35 Domaine Universitaire du Sart-Tilman, 4000, Liege, Belgium. nmeyers@chuliege.be.
Alexandre JadoulDivision of Nuclear Medicine and Oncological Imaging, CHU de Liege, University Hospital of Liege, B35 Domaine Universitaire du Sart-Tilman, 4000, Liege, Belgium.
Claire BernardDivision of Nuclear Medicine and Oncological Imaging, CHU de Liege, University Hospital of Liege, B35 Domaine Universitaire du Sart-Tilman, 4000, Liege, Belgium.
Jean DelwaideDivision of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Liege, Liege, Belgium.
Anne LamproyeDivision of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Liege, Liege, Belgium.
Olivier DetryDivision of Abdominal Surgery and Transplantation, University Hospital of Liege, Liege, Belgium.
Pierre HonoréDivision of Abdominal Surgery and Transplantation, University Hospital of Liege, Liege, Belgium.
Laurent GerardDivision of Radiology, University Hospital of Liege, Liege, Belgium.
Roland HustinxDivision of Nuclear Medicine and Oncological Imaging, CHU de Liege, University Hospital of Liege, B35 Domaine Universitaire du Sart-Tilman, 4000, Liege, Belgium.
Centre Hospitalier Universitaire de Liège · BEUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionStrong correlation has been demonstrated between tumor dose and response and between healthy liver dose and side effects. Individualized dosimetry is increasingly recommended in the current clinical routine. However, hepatic and tumor segmentations could be complex in some cases. The aim of this study is to assess the reproducibility of the tumoral and non-tumoral liver dosimetry in selective internal radiation therapy (SIRT). MATERIAL AND

methodsTwenty-three patients with hepatocellular carcinoma (HCC) who underwent SIRT with glass microspheres were retrospectively included in the study. Tumor (TV) and total liver volumes (TLV), and mean absorbed doses in tumoral liver (TD) and non-tumoral liver (THLD) were determined on the

resultsA strong agreement was observed between all three readers for estimating TLV (ICC 0.98) and THLD (ICC 0.97). Agreement was lower for TV delineation (ICC 0.94) and particularly for TD (ICC 0.73), especially for the highest values. Regarding TD, the CV (%) was 26.5, 26.9, and 20.2 between observers A and B, A and C, and B and C, respectively, and the RDC was 1.5. Regarding THLD, it was 8.5, 12.7, and 9.4, and the RDC was 1.3.

conclusionUsing a standardized methodology, and regardless of the different experiences of the observers, the estimation of THLD is highly reproducible. Although the reproducibility of the assessment of tumor irradiation is overall quite high, large variations may be observed in a limited number of patients.

Indexed as

DosimetryHepatocarcinomaMicrospheresRadioembolizationReproducibility

Identifiers

PMID32399636
PMCPMC7218042
OpenAlexW3026663625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.